Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Thursday, August 18, 2022.

Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR)

Bull Market Weakness (+75) - CNCR is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Keep an eye on CNCR as it may be in the beginning stages of a reversal.

Is it time to buy, sell, or avoid CNCR?

MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

NASDAQ_CNCR
Open High Low CNCR Price Change
17.360 17.260 17.130 17.250 -0.285
Entry Signal

MarketClub’s Trade Triangles for CNCR

long term up The long-term trend has been UP since Aug 8th, 2022 at 17.05

intermediate term up The intermediate-term trend has been UP since Aug 8th, 2022 at 17.05

short term down The short-term trend has been DOWN since Aug 17th, 2022 at 17.50

Smart Scan Analysis for CNCR

Based on our trend formula, CNCR is rated as a +75 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

+75
Smart Scan Analysis for CNCR
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
17.360 17.260 17.130 17.250 -0.285
Prev. Close Volume Bid Ask Time
17.081 5871 2022-08-17 14:09:07
Year High32.32Year High Date2018-03-13
Year Low19.1252Year Low Date2018-10-29
52wk High31.752wk High Date2021-09-03
52wk Low12.7652wk Low Date2022-06-13
Average Volume4,097Shares Outstanding100
Market Cap34MVolatility39.81
Get a free daily analysis and signals for Loncar Cancer Immunotherapy ETF (CNCR) - Request Your Free Report.